Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1465 - 1472 of 11617 results
LPs Push Back Against ‘Pre-Clearance’ Of GP-Led Deals
February 3, 2023| News
ChatGPT's Real Estate Potential Is Big, But Attys Urge Caution
February 3, 2023| News
New Group Practice Information Form for the Stark Law’s Self-Referral Disclosure Protocol
February 2, 2023| Blog| Viewpoint
What’s New in 5G - February 2023
February 2, 2023| Blog| Viewpoint
Final Regulations Issued by Massachusetts Department of Family and Medical Leave – Health Maintenance During Leave
February 1, 2023| Blog| Viewpoint
Priorities, Priorities – FINRA Publishes Its Annual Report of Focus Areas for 2023
February 1, 2023| Blog| Viewpoint
How Mintz Revamped Rainmaker Pay
February 1, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.